Rheumatoid arthritis trials recruiting in North Carolina

All Rheumatoid arthritis trials nationally

Cities in North Carolina

Recruiting trials in North Carolina

• A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic
  NCT07123038 · Phase: Not specified · Ages: 18 Years to 71 Years · Sex: All (male and female) · North Carolina: Durham
• A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
  NCT06747949 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · North Carolina: Charlotte, Durham, Salisbury
• A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
  NCT06733935 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · North Carolina: Charlotte
• A Study of AZD0120 in Autoimmune Diseases
  NCT07295847 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · North Carolina: Chapel Hill
• A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
  NCT07115745 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · North Carolina: Durham
• A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)
  NCT07409103 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · North Carolina: Charlotte, Wilmington
• A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
  NCT06972446 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · North Carolina: Charlotte, Leland
• A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
  NCT06916806 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · North Carolina: Chapel Hill
• AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
  NCT06991114 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · North Carolina: Charlotte, Statesville
• Clinical Outcomes Study of the Nexel Total Elbow
  NCT02469662 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · North Carolina: Charlotte
• EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
  NCT06631638 · Phase: Not applicable (e.g. observational or device study) · Ages: 21 Years and older · Sex: All (male and female) · North Carolina: Gastonia
• Exactech Shoulder Post Market Clinical Follow-up Study
  NCT05603728 · Phase: Not specified · Ages: 21 Years and older · Sex: All (male and female) · North Carolina: Asheville, Durham
• Exactech Vantage Total Ankle System Post Market Clinical Follow-Up - US Only
  NCT05619588 · Phase: Not specified · Ages: 21 Years and older · Sex: All (male and female) · North Carolina: Durham
• Improving Hypertension Control in Rheumatoid Arthritis
  NCT05760898 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · North Carolina: Durham
• Maternal Autoimmune Disease Research Alliance (MADRA) Registry
  NCT03276923 · Phase: Not specified · Ages: No age limits stated · Sex: Female · North Carolina: Durham
• Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
  NCT02418442 · Phase: Not specified · Ages: Up to 21 Years · Sex: All (male and female) · North Carolina: Chapel Hill, Charlotte, Durham, Winston-Salem
• Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
  NCT07404865 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · North Carolina: Charlotte
• Targeted Remotely-delivered Anti-inflammatory Interventions With Exercise for Rheumatoid Arthritis
  NCT06841562 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · North Carolina: Durham
• The Myelin Disorders Biorepository Project
  NCT03047369 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · North Carolina: Winston-Salem
• Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
  NCT07621809 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · North Carolina: Charlotte